Global Intravitreal (IVT) Injectables Market: Overview

Intravitreal (IVT) injectables are used for the administration of medications to patients suffering from retinal disorders. Drugs are administered in the form of injections directly into the vitreous cavity of the eye, which is filled with vitreous humor gel. The procedure for injecting drugs is performed by a skilled ophthalmologist in the outpatient or office setting. Antivascular endothelial growth factor (anti-VEGF) drugs, antibiotics, steroids, antifungals, and antivirals are commonly used drugs for retinal conditions. Eylea, lucentis, and macugen are some of the common IVT injectables available in the market for the treatment of ocular diseases.

Global Intravitreal (IVT) Injectables Market: Key Trends

Increase in the prevalence of retinal disorders such as age-related macular degeneration, retinal vein occlusions, and diabetic retinopathy across the globe are major factors driving the global intravitreal (IVT) injectables market. According to the National Eye Institute (NEI), approximately 2.0 million people in the U.S. were affected with AMD in 2010, and the number is expected to more than double to reach an estimated 5.4 million by 2050. Furthermore, favorable regulatory guidelines for the design and manufacture of intravitreal (IVT) injectables for patient safety are projected to boost the growth of the market during the forecast period. Manufacturers are developing intravitreal (IVT) injectables that are compatible with these regulatory guidelines. Moreover, an increase in focus of industry players on innovation with a strong pipeline of IVT injections for the treatment of retinal conditions is projected to propel global market over the next few years. However, the need for frequent intravitreal injections and risks or complications associated with injectables, including infection and inflammation in the eye, retinal detachment, and vitreous hemorrhage, are anticipated to restrain the global market in the future.

Global Intravitreal (IVT) Injectables Market: Segmentation

The global intravitreal (IVT) injectables market can be segmented based on drug class, application, distribution channel, and region. In terms of drug class, the market can be classified into anti-VEGF, antibiotics, corticosteroids, antifungals, and antivirals. The anti-VEGF segment held a prominent share of the global intravitreal injectables market in 2018. These drugs have the ability to bind to growth factors and suppress the formation of irregular blood vessels in ocular diseases. Moreover, anti-VEGF drugs help minimize fluid leakage associated with these disorders, thereby generating high demand from ophthalmologists. Based on application, the global intravitreal (IVT) injectables market can be categorized into age-related macular degeneration (AMD), endophthalmitis, diabetic retinopathy, retinal vein occlusions, and others. In terms of distribution channel, the market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held a prominent market share in 2018. It is anticipated to continue to dominate the market during the forecast period.

Global Intravitreal (IVT) Injectables Market: Regional Analysis

In terms of region, the global intravitreal (IVT) injectables market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for a prominent share of the global market between 2019 and 2027. A rise in the prevalence of age-related macular degeneration (AMD) is anticipated to drive demand for intravitreal (IVT) injectables in the U.S. Moreover, an intravitreal injection is the most common ophthalmic procedure performed in the country, owing to a favorable reimbursement scenario, which, in turn, is expected to boost market growth in the future. Increase in the geriatric population and rise in the burden of retinal diseases are anticipated to propel demand for intravitreal (IVT) injectables in Europe. Presence of a signficant patient pool suffering from diabetes mellitus in emerging countries such as India and China is a major risk factor for the development of diabetic retinopathy. This is expected to drive demand for intravitreal (IVT) injectables market in Asia Pacific in the coming years.

Global Intravitreal (IVT) Injectables Market: Competitive Landscape

Key players operating in the global intravitreal (IVT) injectables market are Alcon Pharmaceuticals, Novartis, Regeneron Pharmaceuticals Inc., Allergan, Alimera Sciences, Bristol Myers Squibb, Bausch & Lomb, F. Hoffmann-La Roche, Thrombogenics and Valeant Pharmaceuticals International. These players have adopted organic and inorganic growth strategies to expand product portfolio and geographic reach.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.